[ad_1] U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option that…
specialized drugs
-
-
STOCK MARKET
25 million children at risk of getting dangerous but preventable illnesses amid steep backslide in vaccinations
by userby user[ad_1] The coronavirus pandemic has caused the biggest backslide in childhood vaccinations in about 30…
-
STOCK MARKET
Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
by userby user[ad_1] U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
-
STOCK MARKET
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
by userby user[ad_1] A new, highly infectious subvariant of omicron is raising concerns among scientists and health…
-
STOCK MARKET
Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
by userby user[ad_1] Novavax’s NVAX, +0.61% COVID-19 vaccine candidate played a front-and-center role during this week’s debate…
-
STOCK MARKET
CVS, Walmart, Rite Aid limit purchases of Plan B pills as demand surges following Roe ruling
by userby user[ad_1] Some of the nation’s biggest retailers are rationing over-the-counter emergency contraceptive pills as demand…
-
[ad_1] AstraZeneca PLC said Monday that its Enhertu drug has been recommended for approval in…
-
STOCK MARKET
Dr. Fauci’s COVID case was ‘mild’ thanks to being vaccinated and double-boosted, he says
by userby user[ad_1] ““I think I am an example, given my age, of what we’re all talking…
-
[ad_1] Valneva SE’s shares continue to trade higher on Tuesday following news that U.S. peer…
-
STOCK MARKET
Clusters of monkeypox cases are driving up stock prices for some companies
by userby user[ad_1] Growing concern about the emergence of monkeypox in Europe and the U.S. has sent…